Bitdeer Technologies Group vs Regeneron Pharmaceuticals Inc — how do they compare? Bitdeer Technologies Group trades at $12.52 (market cap $2.95B), while Regeneron Pharmaceuticals Inc trades at $655.5 (market cap $69.52B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 23.6× Bitdeer Technologies Group's market cap, and Regeneron Pharmaceuticals Inc pays a 0.57% dividend while Bitdeer Technologies Group pays none. Which is the better fit depends on your goals.
| BTDR | REGN | |
|---|---|---|
Market Cap | $2.95B | $69.52B |
Sector | Technology | Health |
52-Week High | $25.90 | $812.27 |
52-Week Low | $7.28 | $542.52 |
Enterprise Value | $4.71B | $63.47B |
Dividend Yield | — | 0.57% |
Trailing returns across standard periods
Latest headlines on both assets
Bitdeer is a world-leading technology company for blockchain and high-performance computing. It provides comprehensive digital asset mining solutions, including cloud mining, hosting, and data center management.
Read more on BTDR →Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →